Welcome to our dedicated page for Vireo Growth news (Ticker: VREOF), a resource for investors and traders seeking the latest updates and insights on Vireo Growth stock.
Vireo Growth Inc. (VREOF) generates a steady flow of news driven by its activities in the cannabis industry, including medical and adult-use operations, multi-state expansion, and corporate transactions. As a company that describes itself as a pioneering medical cannabis operator founded in 2014, Vireo uses press releases to communicate developments in its retail footprint, cultivation and production capacity, and strategic initiatives.
Recent news items highlight several key themes. One is geographic expansion and market entry. Vireo announced an Agreement and Plan of Merger to acquire Eaze Inc., a vertically integrated cannabis retailer and delivery technology platform with operations in California, Florida, and Colorado. The company states that this transaction is intended to mark its entry into California and Florida and to strengthen its position in Colorado, with Eaze becoming a wholly owned subsidiary upon closing.
Another recurring theme is M&A and capital structure activity. Vireo has reported entering into agreements to acquire a majority of Schwazze’s senior secured convertible notes, participating in a restructuring support agreement that contemplates an asset sale to a new entity to be majority-owned by Vireo, and negotiating an Asset Purchase Agreement to acquire Colorado dispensary assets from PharmaCann Inc. These announcements detail transaction terms, consideration in subordinate voting shares, and conditions such as regulatory approvals.
Operational updates also feature prominently. Vireo issued a release announcing the launch of adult-use cannabis sales in Minnesota at its Green Goods dispensaries, noting that it dispenses both medical and adult-use products at eight locations in the state. Quarterly earnings releases provide summaries of financial performance, state-by-state revenue, and non-GAAP metrics, accompanied by management commentary on integration of acquisitions and portfolio development.
Investors and observers who follow VREOF news can use this stream of announcements to monitor transaction progress, regulatory milestones, market entries, adult-use launches, litigation resolutions, and financial reporting updates, all of which are documented through Globe Newswire releases and linked SEC filings.
Vireo Growth (OTCQX: VREOF) will release first-quarter 2026 financial results for the period ended March 31, 2026 on Tuesday, May 12, 2026, before market open. Management will host a conference call the same day at 8:00 a.m. ET (7:00 a.m. CT) to discuss results and take questions. A live audio webcast will be available in the Events & Presentations section of the company investor relations website and at the provided Q4 Events link. Dial-in numbers and conference ID 1197610 are provided for US, Canada and international callers.
Vireo Growth (OTCQX: VREOF) will acquire FLUENT (OTCQB: CNTMF) in an all‑stock arrangement at an exchange ratio of 0.0705359 Vireo share per FLUENT share. The deal aims to create scale in Florida with ~74 stores and ~144,000 sq ft of canopy, and FLUENT reported ~$71.5M revenue from Florida in 2025. The transaction includes a $30M equitization of debt, expected delisting of FLUENT, voting support agreements (~38.3%), and anticipates closing in Q4 2026, subject to court, shareholder and regulatory approvals.
Vireo Growth (OTCQX: VREOF) and Glass House announced a 50/50 California retail joint venture to combine Vireo's 12 dispensaries and Eaze home delivery operations with Glass House's 11 retail locations into one integrated platform.
The joint venture includes a preferential supply agreement with Glass House, mutual buy/sell rights after five years, and appointment of Cory Azzalino as CEO to lead retail expansion and delivery integration.
Vireo Growth (CSE: VREO; OTCQX: VREOF) completed the acquisition of The Hawthorne Gardening Company from Scotts Miracle-Gro on April 8, 2026. The deal delivers approximately US$35M cash, ~US$58M net working capital and US$20M inventory, totaling ~US$110M of combined cash and working capital.
Consideration consisted of 213 million shares (deemed US$0.60) and 80 million warrants exercisable at US$0.85 for five years. Good Dog now holds ~14% of Vireo, potentially rising to ~19% if warrants are exercised. Vireo nominated Chris Hagedorn for its board; shareholders vote May 29, 2026.
Vireo Growth (OTCQX: VREOF) announced a strategic partnership with Ace Venture of NY to create New York’s first scaled, minority-owned, vertically integrated medical cannabis operator.
Under the agreement, Ace will acquire a 51% ownership interest in Vireo Health of New York, while Vireo will continue providing operational and compliance support.
Vireo Growth (OTCQX: VREOF) closed its acquisition of Eaze Inc. on April 1, 2026, expanding operations into California and Florida and increasing scale across existing markets.
The transaction expands Vireo’s footprint to 10 states with over 160 dispensaries and approximately 800,000 sq. ft. of cultivation and production, adds Eaze’s 67 retail locations and its delivery platform (over 12 million deliveries), and contributes an incremental 15 Colorado dispensaries. Cory Azzalino will lead Vireo’s California business as CEO.
Vireo Growth (OTCQX: VREOF) said its Management Services Agreement with PharmaCann became effective on March 22, 2026, allowing Vireo to manage specified PharmaCann retail assets in Colorado until closing.
Under the Asset Purchase Agreement, Vireo delivered 90,740,741 subordinate voting shares from treasury into escrow with Odyssey Trust Company; those shares will remain in escrow until release at closing, which is expected in Q2 2026 and remains subject to regulatory approval.
Vireo Growth (OTCQX: VREOF) updated a nonbinding MOU to acquire Hawthorne from ScottsMiracle-Gro, targeting completion after five business days and planning a share-based transaction in Q2 2026.
The contemplated deal includes US$35M cash, ~US$50M net working capital, ~US$20M inventory, issuance of 206M shares and warrants for 80M shares exercisable at US$0.85 for five years; appointment of Chris Hagedorn to Vireo’s board is planned upon closing and shareholder approval.
Vireo Growth (CSE: VREO; OTCQX: VREOF) closed its acquisition of certain Schwazze assets on March 24, 2026, acquiring 45 dispensaries (24 in Colorado, 21 in New Mexico) and one manufacturing facility in each state at an assumed share price of $0.661.
The transaction implies an estimated valuation of under 4x pro forma EBITDA. Justin Dye will become chairman of the Colorado and New Mexico business and Forrest Hoffmaster will be CEO of that regional business. Management cites a potential long‑term retail footprint of over 75 dispensaries, subject to approvals and capital.
Vireo Growth (OTCQX: VREOF) reported Q4 FY2025 GAAP revenue of $104.5M, up 317.7% YoY, driven by recent M&A activity. Pro forma Q4 revenue was $104.5M (26.1% above pro forma prior-year). Q4 cash was $122.5M, and multiple Colorado retail acquisitions plus an MOU for Hawthorne are expected to close in H1 2026.
Q4 adjusted EBITDA was $29.5M (28.2% margin); same-store sales ex-Minnesota rose 11.3% YoY, and wholesale increased 55% YoY.